Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced that its GMP laboratory and production facility in Shanghai has successfully passed a fourth consecutive China Food and Drug Administration inspection. Operating since 2012, the 20,000 square foot facility has consistently been certified by a third-party CFDA authorized accreditation agency each year.
http://ift.tt/1FfDLHT
http://ift.tt/1FfDLHT
No comments:
Post a Comment